# Biomat USA Inc – FDA Inspection, Mar 7, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d222881d-5c17-4c81-bf17-a7a9cb8478d1
Source feed: FDA_Inspections

> FDA inspection 1082394 of Biomat USA Inc, March 07, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 606 and 640. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1082394
- Company Name: Biomat USA Inc
- Inspection Date: 2019-03-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 956398 - 2015-12-15
- FDA Inspection 854725 - 2013-11-15
- [FDA Inspection 742308 - 2011-09-09](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/fa7aabc6-8da1-479f-9372-5f6606e37465)
- FDA Inspection 601570 - 2009-08-11

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jennifer-l-sheehan/a49c628d-6eba-4b52-bafc-70785b9ba75e)

Company: https://www.keypedia.com/companies/biomat-usa-inc/367b61cf-95b5-4528-a735-64e8965299d3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
